Developer of a hemoglobin-based oxygen-carrying red blood cell substitute.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2009 | CAPITOL CONSULTING GROUP, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination |
— | |
| 2009 | CAPITOL CONSULTING GROUP, LLC |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| CAPITOL CONSULTING GROUP, LLC | 2 | — |
| Issue | Activities |
|---|---|
| Defense | 2 |
| Budget/Appropriations | 2 |